'Bacterial resistance' presentation slideshows

617 views • 52 slides

Emerging pathogens 2008

Emerging pathogens 2008. Peter H. Gilligan PhD Clinical Microbiology-Immunology Labs UNC Hospitals. How I became a clinical microbiologist. Obtained doctoral degree in microbiology at the University of Kansas

590 views • 45 slides

Pharmaceutical aspects of the development of anti-infectives

589 views • 44 slides

Anti-bacteria Medicine

Anti-bacteria Medicine. Anti-bacteria medicine. Antibiotics: The substance derived from fungi and bacteria which can selectively kill or inhibit bacteria growth Anti-bacteria medicine: Chemically synthesized medicine which can selectively kill or inhibit bacteria growth. Antibacteria medicine.

603 views • 42 slides

Emerging pathogens 2007

Emerging pathogens 2007. Peter H. Gilligan PhD Clinical Microbiology-Immunology Labs UNC Hospitals. How I became a clinical microbiologist. Obtained doctoral degree in microbiology at the University of Kansas

538 views • 42 slides

Antimicrobial Drug Development: a crisis ?

Antimicrobial Drug Development: a crisis ?. Alasdair MacGowan Bristol Centre for Antimicrobial Research & Evaluation University of Bristol/North Bristol NHS Trust 18 th October, 2005. Topics Antibacterial drugs in development (past, present, future)

551 views • 42 slides

Emerging pathogens 2009

Emerging pathogens 2009. Peter H. Gilligan PhD Clinical Microbiology-Immunology Labs UNC Hospitals. How I became a clinical microbiologist. Obtained doctoral degree in microbiology at the University of Kansas

489 views • 38 slides

Lecture 7 Chapter 25

Lecture 7 Chapter 25. Antibacterials: Penicillins & Cephalosporins. Antibacterials. Antibacterials/antimicrobial drugs - Substances that inhibit the growth of or kill bacteria or other microorganisms (microscopic organisms = bacteria, viruses, fungi, protozoa)

537 views • 35 slides

Department of Medical Biotechnology University of Siena Italy

A novel synthetic antimicrobial peptide for the cure of Gram-negative infections. Mechanism of action, efficacy in vivo, toxicity, biodistribution and resistance selection Alessandro Pini pinia@unisi.it. Department of Medical Biotechnology University of Siena Italy. SetLance srl

434 views • 21 slides

Mutations

506 views • 21 slides

Prof. Mohammad Alhumayyd Dr. Aliah Pharmacology Department

Prof. Mohammad Alhumayyd Dr. Aliah Pharmacology Department. Introduction to Antibiotics. Objectives of the Lecture. Classification of antibiotics Misuses of antibiotics Choice of antibiotics Bacterial resistance and ways to prevent it General principles of antibiotic therapy

701 views • 20 slides

Mutations

787 views • 20 slides

Introduction to Antibiotics 1 st yr( Respiratory block) Prof. Azza Elmedany

Introduction to Antibiotics 1 st yr( Respiratory block) Prof. Azza Elmedany. Chemical substances produced by various microorganisms that have the capacity to inhibit or destroy other microorganisms Nowaday they are chemically synthesized drugs.

203 views • 20 slides

Natural Selection

Natural Selection. A Mechanism for Evolutionary Change. Evolution. Change in the genes of a population over time. Evidence: includes fossil record, DNA and protein studies and direct observation. indicates that living things on the earth change over time.

298 views • 19 slides

THE MODERN THEORY OF EVOLUTION

1.28k views • 12 slides

Evaluation of the resistance of bacterial pathogens of synopulmonary infections in children

Evaluation of the resistance of bacterial pathogens of synopulmonary infections in children. L.Chernyshova F.Lapiy National Medical Academy of Postgraduate Education (Kyiv, Ukraine). Background.

227 views • 12 slides

The mechanism of antibiotics

The mechanism of antibiotics. Biol 1220 Synthetic Biology abe pressman & minoo ramanathan. the basics. Used to kill or inhibit the growth of bacteria Classified as bactericidal or bacteriostatic Kill bacteria directly Prevent cell division Classified by target specificity:

124 views • 11 slides